Jun Wu1, Jushuang Li1, Geli Zhu2, Yanxia Zhang2, Zhimin Bi2, Yean Yu2, Bo Huang3, Shouzhi Fu4, Yiqing Tan5, Jianbin Sun6, Xiangyou Li1. 1. Department of Nephrology, Tongren Hospital of Wuhan University (Wuhan Third Hospital), Wuhan University, Wuhan, Hubei, People's Republic of China lixiangyou3@163.com. 2. Department of Nephrology, Tongren Hospital of Wuhan University (Wuhan Third Hospital), Wuhan University, Wuhan, Hubei, People's Republic of China. 3. Department of Respiratory Medicine, Tongren Hospital of Wuhan University (Wuhan Third Hospital), Wuhan University, Wuhan, Hubei, People's Republic of China. 4. Department of Critical Care Medicine, Tongren Hospital of Wuhan University (Wuhan Third Hospital), Wuhan University, Wuhan, Hubei, People's Republic of China. 5. Department of Radiology, Tongren Hospital of Wuhan University (Wuhan Third Hospital), Wuhan University, Wuhan, Hubei, People's Republic of China. 6. Department of Laboratory Medicine, Tongren Hospital of Wuhan University (Wuhan Third Hospital), Wuhan University, Wuhan, Hubei, People's Republic of China.
Abstract
BACKGROUND AND OBJECTIVES: Previous reports on the outbreak of coronavirus disease 2019 were on the basis of data from the general population. Our study aimed to investigate the clinical features of patients on maintenance hemodialysis. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: In this retrospective, single-center study, we included 49 hospitalized patients on maintenance hemodialysis and 52 hospitalized patients without kidney failure (controls) with confirmed coronavirus disease 2019 at Tongren Hospital of Wuhan University from January 30, 2020 to March 10, 2020. Demographic, clinical, laboratory, and radiologic characteristics and treatment and outcomes data were analyzed. The final date of follow-up was March 19, 2020. RESULTS: The median age of 101 patients was 62 years (interquartile range, 49-72). All patients were local residents of Wuhan. In terms of common symptoms, there were differences between patients on hemodialysis and controls (fatigue [59% versus 83%], dry cough [49% versus 71%], and fever [47% versus 90%]). Lymphocyte counts were decreased (0.8×109/L [patients on hemodialysis] versus 0.9×109/L [controls], P=0.02). Comparing patients on hemodialysis with controls, creatine kinase-muscle and brain type, myoglobin, hypersensitive troponin I, B-type natriuretic peptide, and procalcitonin were increased, and the percentage of abnormalities in bilateral lung was higher in computed tomographic scan (82% versus 69%, P=0.15) and unilateral lung was lower (10% versus 27%, P=0.03). Common complications including shock, acute respiratory distress syndrome, arrhythmia, and acute cardiac injury in patients on hemodialysis were significantly higher. Compared with controls, more patients on hemodialysis received noninvasive ventilation (25% versus 6%, P=0.008). As of March 19, 2020, three patients on hemodialysis (6%) were transferred to the intensive care unit and received invasive ventilation. Seven patients on hemodialysis (14%) had died. CONCLUSIONS: The main symptoms of coronavirus disease 2019 pneumonia, including fever and cough, were less common in patients on hemodialysis. Patients on hemodialysis with coronavirus disease 2019 were at higher risk of death.
BACKGROUND AND OBJECTIVES: Previous reports on the outbreak of coronavirus disease 2019 were on the basis of data from the general population. Our study aimed to investigate the clinical features of patients on maintenance hemodialysis. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: In this retrospective, single-center study, we included 49 hospitalized patients on maintenance hemodialysis and 52 hospitalized patients without kidney failure (controls) with confirmed coronavirus disease 2019 at Tongren Hospital of Wuhan University from January 30, 2020 to March 10, 2020. Demographic, clinical, laboratory, and radiologic characteristics and treatment and outcomes data were analyzed. The final date of follow-up was March 19, 2020. RESULTS: The median age of 101 patients was 62 years (interquartile range, 49-72). All patients were local residents of Wuhan. In terms of common symptoms, there were differences between patients on hemodialysis and controls (fatigue [59% versus 83%], dry cough [49% versus 71%], and fever [47% versus 90%]). Lymphocyte counts were decreased (0.8×109/L [patients on hemodialysis] versus 0.9×109/L [controls], P=0.02). Comparing patients on hemodialysis with controls, creatine kinase-muscle and brain type, myoglobin, hypersensitive troponin I, B-type natriuretic peptide, and procalcitonin were increased, and the percentage of abnormalities in bilateral lung was higher in computed tomographic scan (82% versus 69%, P=0.15) and unilateral lung was lower (10% versus 27%, P=0.03). Common complications including shock, acute respiratory distress syndrome, arrhythmia, and acute cardiac injury in patients on hemodialysis were significantly higher. Compared with controls, more patients on hemodialysis received noninvasive ventilation (25% versus 6%, P=0.008). As of March 19, 2020, three patients on hemodialysis (6%) were transferred to the intensive care unit and received invasive ventilation. Seven patients on hemodialysis (14%) had died. CONCLUSIONS: The main symptoms of coronavirus disease 2019 pneumonia, including fever and cough, were less common in patients on hemodialysis. Patients on hemodialysis with coronavirus disease 2019 were at higher risk of death.
Authors: Sibylle Bernard-Stoecklin; Birgit Nikolay; Abdullah Assiri; Abdul Aziz Bin Saeed; Peter Karim Ben Embarek; Hassan El Bushra; Moran Ki; Mamunur Rahman Malik; Arnaud Fontanet; Simon Cauchemez; Maria D Van Kerkhove Journal: Sci Rep Date: 2019-05-14 Impact factor: 4.379
Authors: Qun Li; Xuhua Guan; Peng Wu; Xiaoye Wang; Lei Zhou; Yeqing Tong; Ruiqi Ren; Kathy S M Leung; Eric H Y Lau; Jessica Y Wong; Xuesen Xing; Nijuan Xiang; Yang Wu; Chao Li; Qi Chen; Dan Li; Tian Liu; Jing Zhao; Man Liu; Wenxiao Tu; Chuding Chen; Lianmei Jin; Rui Yang; Qi Wang; Suhua Zhou; Rui Wang; Hui Liu; Yinbo Luo; Yuan Liu; Ge Shao; Huan Li; Zhongfa Tao; Yang Yang; Zhiqiang Deng; Boxi Liu; Zhitao Ma; Yanping Zhang; Guoqing Shi; Tommy T Y Lam; Joseph T Wu; George F Gao; Benjamin J Cowling; Bo Yang; Gabriel M Leung; Zijian Feng Journal: N Engl J Med Date: 2020-01-29 Impact factor: 176.079
Authors: Hon Lok Tang; Au Cheuk; Kwok Hong Chu; William Lee; Sze Ho Wong; Yuk Lun Cheng; Alex Wai Yin Yu; Ka Shun Fung; Wai Kay Tsang; Hilda Wai Han Chan; Kwok Lung Tong Journal: Nephrol Dial Transplant Date: 2003-10 Impact factor: 5.992
Authors: Ping-Nam Wong; Siu-Ka Mak; Kin-Yee Lo; Gensy M W Tong; Yuk Wong; Chi-Leung Watt; Andrew K M Wong Journal: Am J Kidney Dis Date: 2003-11 Impact factor: 8.860
Authors: José Juan Ribés Cruz; Esther Bea Reyes; Jose Graña Fandos; Yolanda Blanco Mateos; María Aparicio Aliaga; Yaiza Aznar Artiles; Belén Alemany Sánchez; Martina Mravcová; Rosa Borrás Vila; Boris Marcelo Gonzales Candia; Igor Romaniouk Jakovler; Miguel Ángel Candel Rosell Journal: Nefrologia (Engl Ed) Date: 2020-10-10
Authors: Dalvir Kular; Irina Chis Ster; Alexander Sarnowski; Eirini Lioudaki; Dandisonba C B Braide-Azikiwe; Martin L Ford; David Makanjuola; Alexandra Rankin; Hugh Cairns; Joyce Popoola; Nicholas Cole; Mysore Phanish; Richard Hull; Pauline A Swift; Debasish Banerjee Journal: Kidney360 Date: 2020-09-10
Authors: Arne Sattler; Stefan Angermair; Helena Stockmann; Katrin Moira Heim; Dmytro Khadzhynov; Sascha Treskatsch; Fabian Halleck; Martin E Kreis; Katja Kotsch Journal: J Clin Invest Date: 2020-12-01 Impact factor: 14.808
Authors: Johan De Meester; Dirk De Bacquer; Maarten Naesens; Bjorn Meijers; Marie M Couttenye; An S De Vriese Journal: J Am Soc Nephrol Date: 2020-11-05 Impact factor: 10.121